statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Analyst Verdict: Absci In The Eyes Of 6 Experts

Latest Ratings for ABSI
 DateFirmActionFromTo Feb 2022BerenbergInitiates Coverage OnBuy Nov 2021B of A SecuritiesDowngradesNeutralUnderperform Aug 2021StifelInitiates Coverage OnHold
 View More...

Absci (NASDAQ:ABSI) Shares Gap Down to $5.61

Absci Co. (NASDAQ:ABSI - Get Free Report) gapped down before the market opened on Tuesday . The stock had previously closed at $5.61, but opened at $5.37. Absci shares last traded at $5.24, with a...

Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference

VANCOUVER, Wash. and NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be...

Absci Corp (ABSI) Earnings: Misses Revenue Estimates and Reports Increased Net Loss

ABSI's Q4 and Full Year 2023 Financial Results Show Continued Investment in AI-Driven Drug DiscoveryRelated Stocks: ABSI...

Absci Reports Business Updates and Fourth Quarter and Full Year 2023 Financial and Operating Results

Initiated IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody Entered into collaboration with AstraZeneca for up to $247M in deal value, plus royalties Strengthened...

ABSI Stock Earnings: Absci Misses EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
ABSI stock results show that Absci missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of...

Absci Co. (NASDAQ:ABSI) Short Interest Update

Absci Co. (NASDAQ:ABSI  Get Free Report) was the target of a large growth in short interest in February. As of February 29th, there was short interest totalling 10,620,000 shares, a growth of...

Absci initiated with bullish view at Scotiabank, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Absci (NASDAQ:ABSI) Rating Reiterated by Truist Financial

Absci (NASDAQ:ABSI  Get Free Report)s stock had its buy rating reiterated by equities researchers at Truist Financial in a research note issued on Wednesday...

Latest Updates of Viva Biotech's Portfolio Companies

Latest Updates of Viva Biotech's Portfolio Companies Latest Updates of Viva Biotech's Portfolio Companies PR Newswire HONG KONG, March 6, 2024 HONG KONG, March 6, 2024 /PRNewswire/ -- Even with the...

Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Volume	735,254.00
52-Wk High	$6.72
52-Wk Low	$1.11

ABSI Absci Corp

About

Feed

News

Sentiment

Earnings

Fundamentals